E-LIB Suche - Ergebnisse für: Dahan, L

1

Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer:

Strickler, J.H ; Satake, H ; George, T.J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506456/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Relevance of biopsy-derived pancreatic organoids in the dev..:

Nicolle, R ; Gayet, O ; Bigonnet, M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tranon.2021.101315. , 2022

Link: https://amu.hal.science/..

3

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-..

4

Relevance of biopsy-derived pancreatic organoids in the dev..:

Nicolle, R ; Gayet, O ; Bigonnet, M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tranon.2021.101315. , 2022

Link: https://hal-amu.archives..

5

887O First multicentric randomized phase II trial investiga..:

Baudin, E ; Walter, Thomas ; Beron, A...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2022.07.1013. , 2022

Link: https://hal.science/hal-..

6

Relevance of biopsy-derived pancreatic organoids in the dev..:

R. Nicolle ; O. Gayet ; M. Bigonnet...
http://www.sciencedirect.com/science/article/pii/S1936523321003065. , 2022

Link: https://doi.org/10.1016/..

7

A phase II study of retifanlimab (INCMGA00012) in patients ..:

Rao, S ; Anandappa, G ; Dahan, L...
ESMO Open;7(4). , 2022

Link: https://hdl.handle.net/1..

8

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-..

9

Sublingual Sufentanil versus Standard-of-Care (Patient-Cont..:

Groen JV ; Boon SC ; Minderhoud MW...
https://www.dovepress.com/sublingual-sufentanil-versus-standard-of-care-patient-controlled-analg-peer-reviewed-fulltext-article-JPR. , 2022

Link: https://doaj.org/article..

10

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-..

11

A phase II study of retifanlimab (INCMGA00012) in patients ..:

Rao, S ; Anandappa, G ; Capdevila, J...
Rao , S , Anandappa , G , Capdevila , J , Dahan , L , Evesque , L , Kim , S , Saunders , M P , Gilbert , D C , Jensen , L H , Samalin , E , Spindler , K L , Tamberi , S , Demols , A , Guren , M G , Arnold , D , Fakih , M , Kayyal , T , Cornfeld , M , Tian , C , Catlett , M , Smith , M & Spano , J P 2022 , ' A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) ' , ESMO Open , vol. 7 , no. 4 , 100529 . https://doi.org/10.1016/j.esmoop.2022.100529. , 2022

Link: https://pure.au.dk/porta..

12

The Use of Muscle Relaxants and Reversal Agents in a Settin..:

Martini CH ; Honing GHM ; Bash LD...
https://www.dovepress.com/the-use-of-muscle-relaxants-and-reversal-agents-in-a-setting-without-c-peer-reviewed-fulltext-article-TCRM. , 2022

Link: https://doaj.org/article..

13

Sublingual Sufentanil versus Standard-of-Care (Patient-Cont..:

Groen, Jesse Vincent ; Boon, SC ; Minderhoud, MW...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JPR.S363545. , 2022

Link: https://www.dovepress.co..

14

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-..

15

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-..